Clinical trial
A Phase I Study of the Mass Balance of a Single Oral Administration of [14C]TPN171H in Healthy Male Subjects
NCT04655872 is registered in ClinicalTrials.gov with Vigonvita Life Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I Study of the Mass Balance of a Single Oral Administration of [14C]TPN171H in Healthy Male Subjects
- Lead sponsor
- Vigonvita Life Sciences
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- November 26, 2020
- Completion date
- January 27, 2021
- Enrollment
- 6 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy male subjects